Dr. Noha Sharafeldin, MD, MSc, PhD
Claim this profileUniversity of Alabama at Birmingham
Affiliated Hospitals
University Of Alabama At Birmingham
Clinical Trials Noha Sharafeldin, MD, MSc, PhD is currently running
Diet and Cognitive Training
for Blood Cancer Survivors
The goal of this clinical trial is to examine feasibility of a cognitive intervention program in blood cancer survivors. The main questions it aims to answer are: * is it feasible to combine a ketogenic diet supplementation and online cognitive training in an intervention program * will patients using the combined intervention program have improved cognitive functioning compared to those who don't use it * how long will the intervention programs effects last Participants randomized to the intervention arm will consume an exogenous ketogenic supplementation and use an online cognitive training program for 12 weeks, while waitlist arm functions as a control group and will receive the online cognitive training only after a wait period of 12 weeks. Researchers will compare the intervention and waitlist control groups to see if the intervention improves cognitive functioning.
Recruiting
1 award
N/A
Cognitive Training
for Post-Transplant Cognitive Impairment
A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HCT) survivors using the cognitive training Lumosity program. In addition, patients' interest in receiving information regarding genetic risk of cognitive impairment post-HCT will be measured.
Recruiting
1 award
N/A
4 criteria
More about Noha Sharafeldin, MD, MSc, PhD
Clinical Trial Related
3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Noha Sharafeldin, MD, MSc, PhD has experience with
- Lumosity
- Modified Ketogenic Diet Using An Exogenous Ketogenic Formula
- Online Cognitive Training
Breakdown of trials Noha Sharafeldin, MD, MSc, PhD has run
Cancer
Blood Cancers
Cognitive Impairment
Bone Marrow Transplant
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Noha Sharafeldin, MD, MSc, PhD specialize in?
Noha Sharafeldin, MD, MSc, PhD focuses on Cancer and Blood Cancers. In particular, much of their work with Cancer has involved treating patients, or patients who are undergoing treatment.
Is Noha Sharafeldin, MD, MSc, PhD currently recruiting for clinical trials?
Yes, Noha Sharafeldin, MD, MSc, PhD is currently recruiting for 2 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Noha Sharafeldin, MD, MSc, PhD has studied deeply?
Yes, Noha Sharafeldin, MD, MSc, PhD has studied treatments such as Lumosity, Modified ketogenic diet using an exogenous ketogenic formula, Online cognitive training.
What is the best way to schedule an appointment with Noha Sharafeldin, MD, MSc, PhD?
Apply for one of the trials that Noha Sharafeldin, MD, MSc, PhD is conducting.
What is the office address of Noha Sharafeldin, MD, MSc, PhD?
The office of Noha Sharafeldin, MD, MSc, PhD is located at: University of Alabama at Birmingham, Birmingham, Alabama 35233 United States. This is the address for their practice at the University of Alabama at Birmingham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.